Alkermes (ALKS) Non-Current Deffered Revenue (2011 - 2022)

Alkermes (ALKS) reported Non-Current Deffered Revenue of $6.4 million for Q3 2022, down 50.25% year-over-year from $12.9 million in Q3 2021, and down 44.3% quarter-over-quarter from $11.5 million in Q4 2021.

Alkermes (ALKS) Non-Current Deffered Revenue (2011 - 2022) Analysis & Trends

Alkermes (ALKS) has 12 years of Non-Current Deffered Revenue data on file, last reported at $6.4 million in Q3 2022.

  • Non-Current Deffered Revenue for Q3 2022 came in at $6.4 million, down 50.25% year-over-year; the trailing twelve-month figure through Sep 2022 was $6.4 million (down 50.25% YoY), and the FY2021 annual result was $11.5 million, down 29.92% from the prior year.
  • Non-Current Deffered Revenue fell to $6.4 million in Q3 2022 per ALKS's latest filing, from $11.5 million in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $22.1 million in Q4 2019 and troughed at $5.0 million in Q3 2018.
  • A 5-year average of $12.8 million and a median of $11.6 million in 2019 frame the typical range for Non-Current Deffered Revenue.
  • The sharpest annual moves came in 2019 and 2022: Non-Current Deffered Revenue jumped 131.69% in 2019, then tumbled 50.25% in 2022.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $9.5 million in 2018, then jumped by 131.69% to $22.1 million in 2019, then decreased by 25.7% to $16.4 million in 2020, then slipped by 29.92% to $11.5 million in 2021, then slumped by 44.3% to $6.4 million in 2022.
  • Business Quant data shows ALKS's Non-Current Deffered Revenue at $6.4 million in Q3 2022, $11.5 million in Q4 2021, and $12.9 million in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn -
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2022 6.40 Mn
Dec 31, 2021 11.49 Mn
Sep 30, 2021 12.86 Mn
Jun 30, 2021 14.17 Mn
Mar 31, 2021 14.75 Mn
Dec 31, 2020 16.40 Mn
Sep 30, 2020 18.64 Mn
Jun 30, 2020 18.88 Mn
Mar 31, 2020 21.16 Mn
Dec 31, 2019 22.07 Mn
Sep 30, 2019 11.19 Mn
Jun 30, 2019 11.62 Mn
Mar 31, 2019 11.34 Mn
Dec 31, 2018 9.53 Mn
Sep 30, 2018 5.01 Mn
Jun 30, 2018 5.86 Mn
Mar 31, 2018 6.17 Mn
Dec 31, 2017 5.66 Mn
Sep 30, 2017 6.13 Mn
Jun 30, 2017 6.78 Mn